Enroll"We enrolled 340 participants across 12 states without opening a single site."
Free · 5 questions · Personalized scorecard
Real-time participant enrollment · No site visits required
The numbers that make the case for decentralization.
Your CRA team spends 60% of their time on planes, not data.
On-site monitoring visits cost $6,800–$12,000 each. Multi-site Phase III trials run 200+ visits. Clinical ops directors are managing travel logistics instead of protocol quality.
Remote monitoring that replaces 90% of on-site visits
The trial comes to the participant, not the other way around
44% of participants say travel to clinic is "very burdensome." They leave.
The average Phase III participant travels 49 miles per visit. Rare disease patients travel further. When life intervenes, they drop out — and you absorb a $19,533 replacement cost per lost participant.
Your EDC has 2,300 open queries. Your statistician has a flight in 4 days.
Manual data entry from paper forms creates cascading query backlogs. Database lock slips by weeks. Each week of delay costs sponsors $600K–$8M in delayed approval revenue.
Clean data from the moment of capture
Score Your Trial's Decentralization Readiness
Answer 5 questions about your current protocol. Receive a personalized scorecard showing your dropout risk, DCT fit score, and a phase-specific decentralization roadmap — gated behind your work email so we can follow up with specifics.
5 questions · 2 minutes · Personalized to your protocol
Your protocol shows strong alignment with decentralized execution. Estimated dropout reduction: 38%.